Linagliptin CAS 668270-12-0 Nadiifinta ≥99.0% (HPLC) Sawirka Warshada

Linagliptin CAS 668270-12-0 Nadiifinta ≥99.0% (HPLC) Warshada

Sharaxaad Gaaban:

Magaca Kiimikada: Linagliptin

CAS: 668270-12-0

Daahirsanaanta: ≥99.0% (HPLC)

Muuqashada: Caddaan ama Off-White Crystalline Powder

Linagliptin oo loogu talagalay daawaynta nooca II ee sonkorowga mellitus

API, Tayo Sare, Wax Soo Saarka Ganacsiga

E-Mail: alvin@ruifuchem.com

Email noogu soo dir

Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Soo-saarka wax-soo-saarka, Nadiifinta Sare, Wax-soo-saarka Ganacsiga
Magaca Kiimikada: Linagliptin
CAS: 668270-12-0

Guryaha Kiimikada:

Magaca Kiimikada	Linagliptin
La mid ah	BI-1356;8-[(3R) -3-Amino-1-piperidinyl] -7- (2-butynyl) -3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H -purine-2,6-dione
Lambarka CAS	668270-12-0
Lambarka CAT	RF-API105
Heerka Saamiyada	Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan
Qaanuunka molecular	C25H28N8O2
Miisaanka Molecular	472.54
Meesha dhalaalaysa	197.0 ilaa 200.0 ℃
Solubility	Ku milmay DMSO
Summada	Kiimikada Ruifu

Tilmaamaha:

Shayga	Tilmaamaha
Muuqashada	Caddaan ama Banaan-cad budada Crystalline
NMR	Waafaqsan Qaab-dhismeedka
Daahirnimada / Habka Falanqaynta	≥99.0% (HPLC)
Khasaare xagga qalajinta	≤0.50%
Hadhaaga dabka	≤0.10%
Biraha culus	≤10pm
Walxaha laxidhiidha
Xumaanta Keliya	≤0.50%
Wadarta wasakhda	≤1.0%
Isomer	≤0.15%
Xalalka Haraaga ah
Methanol	≤3000pm
Isopropanol	≤5000ppm
DMF	≤800pm
Dichloromethane	≤600pm
Heerka Imtixaanka	Heerka Ganacsiga
Isticmaalka	API

Xidhmada & Kaydinta:

Xidhmada: Dhalo, bacda bireed ee aluminium, 25kg/Drum kartoonada, ama sida waafaqsan shuruudaha macmiilka.

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka iyo qoyaanka.

Faa'iidooyinka:

FAQ:

Codsiga:

Linagliptin (CAS: 668270-12-0) waa ka hortag DPP-4 oo ay samaysay Boehringer Ingelheim daawaynta nooca II ee sonkorowga.Laba astaamood oo farmaajo ah oo ka dhigaya linagliptin marka laga reebo kuwa kale ee DPP-4 inhibitors waa inay leedahay astaan-farmakokinetic aan toos ahayn oo aan marka hore meesha laga saarin nidaamka kelyaha.Linagliptin (maalintii hal mar) waxaa ansixiyay FDA US 2dii Maajo 2011 daawaynta nooca II ee sonkorowga.Waxaa suuq geynaya Boehringer Ingelheim iyo Lilly.Linagliptin, oo lagu iibiyo magaca sumadda Tradjenta iyo kuwa kale.Waxa si wadajir ah loo isticmaalaa jimicsi iyo cunto.